AlloCure, Stem Cell Therapy for Kidney Failure
July 9th, 2010
No comments
AlloCure, the developer of an adult stem cell therapy for severe kidney disease, has moved its headquarters from Salt Lake City to Burlington, MA and hired a new President and CEO, Robert Brenner, MD. AlloCure is preparing for Phase 2 Trials in Acute Kidney Injury and has reached an important milestone in their evolution, with the completion of enrollment in a Phase 1 trial in acute kidney injury Read more…
